Laurence Fox
Family Medicine · Federal Way, WANPI 1821007410
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Orexo US, Inc. accounts for 66.0% of it on its own, with 14 other manufacturers making up the rest. Among family medicine clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orexo US, Inc.$1K
- Pfizer$167
- Exact Sciences$113
- Boehringer Ingelheim$66
- Lilly USA, LLC$62
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$45
- plus $183 from 9 others
What the payments were for
- Food & beverage$1,869100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orexo US, Inc. | 97 | $1,233 |
| Pfizer | 9 | $167 |
| Exact Sciences | 4 | $113 |
| Boehringer Ingelheim | 4 | $66 |
| Lilly USA, LLC | 4 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Grifols USA, LLC | 2 | $33 |
| MDD US Operations, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Alkermes, Inc. | 1 | $12 |
| Antares Pharma, Inc. | 1 | $12 |
How this compares
$1,869 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 24 | $1,100 |
| Estradiol (Once Weekly)Estradiol | 13 | $739 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $338 |
| Levothyroxine Sodium | 21 | $183 |
| Doxycycline Hyclate | 11 | $74 |
| Atenolol | 11 | $68 |
| Methocarbamol | 11 | $66 |
| Clonazepam | 12 | $59 |
| Lisinopril | 23 | $37 |
| Amlodipine Besylate | 16 | $21 |
| Anastrozole | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Federal Way
- Ramon SanchezFederal Way$14K
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.